Evidence map›Paper›PMID 36516197›Full record

Trial reportPloS one2022

Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis.

Tisungane Mvalo, Andrew G Smith, Michelle Eckerle, Mina C Hosseinipour, Davie Kondowe, Dhananjay Vaidya, Yisi Liu, Kelly Corbett, Dan Nansongole, Takondwa A Mtimaukanena and 2 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Tisungane MvaloUniversity of North Carolina Project Malawi, Lilongwe, Malawi.ORCID 0000-0002-6775-7919
Andrew G SmithDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Michelle EckerleDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States of America.
Mina C HosseinipourUniversity of North Carolina Project Malawi, Lilongwe, Malawi.ORCID 0000-0003-2174-313X
Davie KondoweUniversity of North Carolina Project Malawi, Lilongwe, Malawi.
Dhananjay VaidyaDepartment of Medicine, Epidemiology and the BEAD Core, Johns Hopkins University, Baltimore, MD, United States of America.ORCID 0000-0002-7164-1601
Yisi LiuDepartment of Pediatrics and the BEAD Core, Johns Hopkins University, Baltimore, MD, United States of America.
Kelly CorbettDepartment of Pediatrics, Section of Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States of America.
Dan NansongoleUniversity of North Carolina Project Malawi, Lilongwe, Malawi.
Takondwa A MtimaukanenaUniversity of North Carolina Project Malawi, Lilongwe, Malawi.
Norman LufesiMalawi Ministry of Heath, Lilongwe, Malawi.
Eric D McCollumEudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Global Program for Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.
Johns Hopkins University · USUniversity of Malawi · MWUniversity of North Carolina at Chapel Hill · USCincinnati Children's Hospital Medical Center · USDartmouth–Hitchcock Medical Center · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia.

methodsParticipants were 1-59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3-6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics.

resultsFrom June 2015-March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure.

conclusionSevere malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes.

Indexed as

MalnutritionPneumoniaAnti-Bacterial AgentsCeftriaxoneChildChild, PreschoolHumansInfantMalawiTreatment FailureWorld Health OrganizationAnti-Bacterial AgentsCeftriaxone

Identifiers

PMID36516197
PMCPMC9750006
OpenAlexW4311438961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.